Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.B of A Securities Analyst
Greg Harrison is an analyst at B of A Securities. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/15/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 11/20/2025 | AGIO | Buy Now | Agios Pharmaceuticals | $26.85 | 19.18% | $54 → $32 | Maintains | Buy | Get Alert | |
| 10/27/2025 | NTLA | Buy Now | Intellia Therapeutics | $9.15 | 227.94% | $36 → $30 | Maintains | Buy | Get Alert | |
| 09/02/2025 | UTHR | Buy Now | United Therapeutics | $500.30 | -7.46% | $314 → $463 | Maintains | Neutral | Get Alert | |
| 08/28/2025 | MLYS | Buy Now | Mineralys Therapeutics | $36.02 | 19.38% | $38 → $43 | Maintains | Buy | Get Alert | |
| 08/07/2025 | TVTX | Buy Now | Travere Therapeutics | $35.00 | -11.43% | $30 → $31 | Maintains | Sector Outperform | Get Alert | |
| 08/06/2025 | OCUL | Buy Now | Ocular Therapeutix | $14.17 | 41.14% | $22 → $20 | Maintains | Sector Outperform | Get Alert | |
| 08/06/2025 | BBIO | Buy Now | BridgeBio Pharma | $73.90 | -22.87% | $55 → $57 | Maintains | Sector Outperform | Get Alert | |
| 08/05/2025 | VRTX | Buy Now | Vertex Pharmaceuticals | $457.05 | -4.17% | $442 → $438 | Maintains | Sector Perform | Get Alert | |
| 08/01/2025 | ALNY | Buy Now | Alnylam Pharmaceuticals | $391.50 | 14.94% | $342 → $450 | Maintains | Sector Outperform | Get Alert | |
| 07/28/2025 | AGIO | Buy Now | Agios Pharmaceuticals | $26.85 | 142.09% | $71 → $65 | Maintains | Sector Outperform | Get Alert | |
| 07/25/2025 | RCKT | Buy Now | Rocket Pharmaceuticals | $3.42 | 16.96% | $9 → $4 | Downgrade | Buy → Neutral | Get Alert | |
| 07/22/2025 | AGIO | Buy Now | Agios Pharmaceuticals | $26.85 | 89.94% | $52 → $51 | Maintains | Buy | Get Alert | |
| 07/14/2025 | GOSS | Buy Now | Gossamer Bio | $3.88 | 183.51% | → $11 | Initiates | → Sector Outperform | Get Alert | |
| 07/02/2025 | ARCT | Buy Now | Arcturus Therapeutics | $7.11 | 392.26% | $32 → $35 | Maintains | Sector Outperform | Get Alert | |
| 06/11/2025 | UTHR | Buy Now | United Therapeutics | $500.30 | -37.04% | $321 → $315 | Maintains | Neutral | Get Alert | |
| 06/02/2025 | VERA | Buy Now | Vera Therapeutics | $47.74 | 36.15% | $55 → $65 | Maintains | Sector Outperform | Get Alert | |
| 05/28/2025 | RCKT | Buy Now | Rocket Pharmaceuticals | $3.42 | 455.56% | $51 → $19 | Maintains | Sector Outperform | Get Alert | |
| 05/28/2025 | LQDA | Buy Now | Liquidia | $34.19 | 8.22% | $36 → $37 | Maintains | Sector Outperform | Get Alert | |
| 05/28/2025 | ARCT | Buy Now | Arcturus Therapeutics | $7.11 | 350.07% | → $32 | Initiates | → Sector Outperform | Get Alert | |
| 05/27/2025 | RCKT | Buy Now | Rocket Pharmaceuticals | $3.42 | 835.67% | $34 → $32 | Maintains | Buy | Get Alert | |
| 05/12/2025 | VERA | Buy Now | Vera Therapeutics | $47.74 | 15.21% | $60 → $55 | Maintains | Sector Outperform | Get Alert | |
| 05/12/2025 | RCKT | Buy Now | Rocket Pharmaceuticals | $3.42 | 1391.23% | $52 → $51 | Maintains | Sector Outperform | Get Alert | |
| 05/12/2025 | KROS | Buy Now | Keros Therapeutics | $21.20 | 22.64% | $41 → $26 | Maintains | Sector Outperform | Get Alert | |
| 05/08/2025 | APLS | Buy Now | Apellis Pharmaceuticals | $24.55 | -18.53% | $28 → $20 | Maintains | Sector Perform | Get Alert | |
| 05/08/2025 | GERN | Buy Now | Geron | $1.32 | 13.64% | $4 → $1.5 | Downgrade | Sector Outperform → Sector Perform | Get Alert | |
| 05/06/2025 | VRTX | Buy Now | Vertex Pharmaceuticals | $457.05 | -3.29% | $450 → $442 | Maintains | Sector Perform | Get Alert | |
| 05/05/2025 | LQDA | Buy Now | Liquidia | $34.19 | 5.29% | $34 → $36 | Maintains | Sector Outperform | Get Alert | |
| 05/02/2025 | AGIO | Buy Now | Agios Pharmaceuticals | $26.85 | 164.43% | $74 → $71 | Maintains | Sector Outperform | Get Alert | |
| 05/01/2025 | UTHR | Buy Now | United Therapeutics | $500.30 | -35.84% | $314 → $321 | Maintains | Neutral | Get Alert | |
| 04/30/2025 | BBIO | Buy Now | BridgeBio Pharma | $73.90 | -25.58% | $52 → $55 | Maintains | Sector Outperform | Get Alert | |
| 04/21/2025 | UTHR | Buy Now | United Therapeutics | $500.30 | -37.24% | $314 → $314 | Upgrade | Underperform → Neutral | Get Alert | |
| 04/02/2025 | APLS | Buy Now | Apellis Pharmaceuticals | $24.55 | 26.27% | $30 → $31 | Maintains | Sector Perform | Get Alert | |
| 03/31/2025 | ALNY | Buy Now | Alnylam Pharmaceuticals | $391.50 | -12.64% | $338 → $342 | Maintains | Sector Outperform | Get Alert | |
| 03/21/2025 | ALNY | Buy Now | Alnylam Pharmaceuticals | $391.50 | -13.67% | $300 → $338 | Maintains | Sector Outperform | Get Alert | |
| 03/20/2025 | LQDA | Buy Now | Liquidia | $34.19 | -0.56% | $30 → $34 | Maintains | Sector Outperform | Get Alert | |
| 03/10/2025 | BEAM | Buy Now | Beam Therapeutics | $26.91 | 48.64% | → $40 | Upgrade | Sector Perform → Sector Outperform | Get Alert | |
| 03/03/2025 | RCKT | Buy Now | Rocket Pharmaceuticals | $3.42 | 1420.47% | $51 → $52 | Maintains | Sector Outperform | Get Alert | |
| 03/03/2025 | IRON | Buy Now | Disc Medicine | $92.00 | -18.48% | $73 → $75 | Maintains | Sector Outperform | Get Alert | |
| 03/03/2025 | BEAM | Buy Now | Beam Therapeutics | $26.91 | -7.1% | $24 → $25 | Maintains | Sector Perform | Get Alert | |
| 02/27/2025 | GERN | Buy Now | Geron | $1.32 | 203.03% | $6 → $4 | Maintains | Sector Outperform | Get Alert | |
| 02/21/2025 | BBIO | Buy Now | BridgeBio Pharma | $73.90 | -29.63% | $49 → $52 | Maintains | Sector Outperform | Get Alert | |
| 02/14/2025 | ALNY | Buy Now | Alnylam Pharmaceuticals | $391.50 | -23.37% | $310 → $300 | Maintains | Sector Outperform | Get Alert | |
| 02/12/2025 | TVTX | Buy Now | Travere Therapeutics | $35.00 | -8.57% | $27 → $32 | Maintains | Sector Outperform | Get Alert | |
| 02/12/2025 | BBIO | Buy Now | BridgeBio Pharma | $73.90 | -33.69% | $48 → $49 | Maintains | Sector Outperform | Get Alert | |
| 02/11/2025 | VRTX | Buy Now | Vertex Pharmaceuticals | $457.05 | -1.54% | $433 → $450 | Maintains | Sector Perform | Get Alert | |
| 01/31/2025 | VRTX | Buy Now | Vertex Pharmaceuticals | $457.05 | -5.26% | $430 → $433 | Maintains | Sector Perform | Get Alert | |
| 01/22/2025 | IRON | Buy Now | Disc Medicine | $92.00 | -20.65% | $70 → $73 | Maintains | Sector Outperform | Get Alert | |
| 01/16/2025 | KROS | Buy Now | Keros Therapeutics | $21.20 | 93.4% | $44 → $41 | Maintains | Sector Outperform | Get Alert | |
| 12/23/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $457.05 | -5.92% | $426 → $430 | Maintains | Sector Perform | Get Alert | |
| 12/13/2024 | KROS | Buy Now | Keros Therapeutics | $21.20 | 107.55% | $77 → $44 | Maintains | Sector Outperform | Get Alert | |
| 12/09/2024 | AGIO | Buy Now | Agios Pharmaceuticals | $26.85 | 179.33% | $53 → $75 | Maintains | Sector Outperform | Get Alert | |
| 12/03/2024 | KROS | Buy Now | Keros Therapeutics | $21.20 | 263.21% | $76 → $77 | Maintains | Buy | Get Alert | |
| 11/25/2024 | BBIO | Buy Now | BridgeBio Pharma | $73.90 | -35.05% | $45 → $48 | Maintains | Sector Outperform | Get Alert | |
| 11/15/2024 | BBIO | Buy Now | BridgeBio Pharma | $73.90 | -39.11% | $44 → $45 | Maintains | Sector Outperform | Get Alert | |
| 11/06/2024 | APLS | Buy Now | Apellis Pharmaceuticals | $24.55 | 22.2% | $35 → $30 | Maintains | Sector Perform | Get Alert | |
| 11/05/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $457.05 | 6.33% | $480 → $486 | Maintains | Sector Perform | Get Alert | |
| 11/05/2024 | IRON | Buy Now | Disc Medicine | $92.00 | -23.91% | $62 → $70 | Maintains | Sector Outperform | Get Alert | |
| 11/01/2024 | TVTX | Buy Now | Travere Therapeutics | $35.00 | -22.86% | $23 → $27 | Maintains | Sector Outperform | Get Alert | |
| 11/01/2024 | ALNY | Buy Now | Alnylam Pharmaceuticals | $391.50 | -20.82% | $305 → $310 | Maintains | Sector Outperform | Get Alert | |
| 11/01/2024 | AGIO | Buy Now | Agios Pharmaceuticals | $26.85 | 97.39% | $51 → $53 | Maintains | Sector Outperform | Get Alert | |
| 10/16/2024 | IRON | Buy Now | Disc Medicine | $92.00 | -32.61% | → $62 | Initiates | → Sector Outperform | Get Alert | |
| 10/16/2024 | TVTX | Buy Now | Travere Therapeutics | $35.00 | -34.29% | → $23 | Initiates | → Sector Outperform | Get Alert | |
| 10/16/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $457.05 | 5.02% | → $480 | Initiates | → Sector Perform | Get Alert | |
| 10/16/2024 | ALNY | Buy Now | Alnylam Pharmaceuticals | $391.50 | -22.09% | → $305 | Initiates | → Sector Outperform | Get Alert | |
| 10/16/2024 | APLS | Buy Now | Apellis Pharmaceuticals | $24.55 | 42.57% | → $35 | Initiates | → Sector Perform | Get Alert | |
| 10/16/2024 | VERA | Buy Now | Vera Therapeutics | $47.74 | 25.68% | → $60 | Initiates | → Sector Outperform | Get Alert | |
| 10/16/2024 | KROS | Buy Now | Keros Therapeutics | $21.20 | 263.21% | → $77 | Initiates | → Sector Outperform | Get Alert | |
| 10/16/2024 | EYPT | Buy Now | EyePoint Pharmaceuticals | $16.50 | 9.09% | → $18 | Initiates | → Sector Outperform | Get Alert | |
| 10/16/2024 | BEAM | Buy Now | Beam Therapeutics | $26.91 | -10.81% | → $24 | Initiates | → Sector Perform | Get Alert | |
| 10/16/2024 | AGIO | Buy Now | Agios Pharmaceuticals | $26.85 | 89.94% | → $51 | Initiates | → Sector Outperform | Get Alert | |
| 10/16/2024 | LQDA | Buy Now | Liquidia | $34.19 | -12.26% | → $30 | Initiates | → Sector Outperform | Get Alert | |
| 10/16/2024 | GERN | Buy Now | Geron | $1.32 | 354.55% | → $6 | Initiates | → Sector Outperform | Get Alert | |
| 10/16/2024 | RCKT | Buy Now | Rocket Pharmaceuticals | $3.42 | 1361.99% | → $50 | Initiates | → Sector Outperform | Get Alert | |
| 10/16/2024 | OCUL | Buy Now | Ocular Therapeutix | $14.17 | 55.26% | → $22 | Initiates | → Sector Outperform | Get Alert | |
| 10/16/2024 | BBIO | Buy Now | BridgeBio Pharma | $73.90 | -40.46% | → $44 | Initiates | → Sector Outperform | Get Alert | |
| 08/01/2024 | UTHR | Buy Now | United Therapeutics | $500.30 | -44.03% | $303 → $280 | Maintains | Underperform | Get Alert | |
| 12/21/2023 | LQDA | Buy Now | Liquidia | $34.19 | -56.13% | $13 → $15 | Maintains | Buy | Get Alert | |
| 12/15/2023 | BEAM | Buy Now | Beam Therapeutics | $26.91 | 30.06% | → $35 | Downgrade | Buy → Neutral | Get Alert | |
| 09/22/2023 | TVTX | Buy Now | Travere Therapeutics | $35.00 | -22.86% | $41 → $27 | Maintains | Buy | Get Alert | |
| 07/26/2023 | KROS | Buy Now | Keros Therapeutics | $21.20 | 206.6% | → $65 | Initiates | → Buy | Get Alert | |
| 06/13/2023 | NTLA | Buy Now | Intellia Therapeutics | $9.15 | 894.75% | $89 → $91 | Maintains | Buy | Get Alert | |
| 05/02/2023 | TVTX | Buy Now | Travere Therapeutics | $35.00 | 11.43% | $52 → $39 | Maintains | Buy | Get Alert | |
| 05/01/2023 | STOK | Buy Now | Stoke Therapeutics | $31.81 | -62.28% | $9 → $12 | Upgrade | Underperform → Neutral | Get Alert | |
| 04/28/2023 | SGMO | Buy Now | Sangamo Therapeutics | $0.44 | 237.15% | $5 → $1.5 | Downgrade | Neutral → Underperform | Get Alert | |
| 03/07/2023 | MLYS | Buy Now | Mineralys Therapeutics | $36.02 | 8.27% | → $39 | Initiates | → Buy | Get Alert | |
| 12/23/2022 | RCKT | Buy Now | Rocket Pharmaceuticals | $3.42 | 923.39% | $38 → $35 | Maintains | Buy | Get Alert | |
| 11/18/2022 | EDIT | Buy Now | Editas Medicine | $2.49 | 502.63% | $18 → $15 | Maintains | Neutral | Get Alert | |
| 11/08/2022 | OMER | Buy Now | Omeros | $9.15 | -67.21% | → $3 | Downgrade | Neutral → Underperform | Get Alert | |
| 09/29/2022 | EDIT | Buy Now | Editas Medicine | $2.49 | 623.15% | → $18 | Initiates | → Neutral | Get Alert | |
| 09/29/2022 | SNTI | Buy Now | Senti Biosciences | $1.15 | 508.7% | → $7 | Initiates | → Buy | Get Alert | |
| 09/12/2022 | NLTX | Buy Now | Neoleukin Therapeutics | — | — | → $1 | Downgrade | Buy → Underperform | Get Alert | |
| 06/16/2022 | NTLA | Buy Now | Intellia Therapeutics | $9.15 | 665.19% | → $70 | Initiates | → Buy | Get Alert | |
| 06/08/2022 | RDUS | Buy Now | Radius Health | — | — | → $8 | Upgrade | Underperform → Neutral | Get Alert | |
| 06/08/2022 | ISEE | Buy Now | IVERIC bio | — | — | → $18 | Initiates | → Buy | Get Alert | |
| 05/26/2022 | LQDA | Buy Now | Liquidia | $34.19 | -64.9% | → $12 | Initiates | → Buy | Get Alert | |
| 05/23/2022 | ATHX | Buy Now | Athersys | — | — | $1 → $0.25 | Downgrade | Neutral → Underperform | Get Alert | |
| 03/16/2022 | STOK | Buy Now | Stoke Therapeutics | $31.81 | 25.75% | $43 → $40 | Maintains | Buy | Get Alert | |
| 03/16/2022 | S | Buy Now | SentinelOne | $14.75 | 266.1% | $67 → $54 | Maintains | Buy | Get Alert | |
| 03/16/2022 | ATHX | Buy Now | Athersys | — | — | $1.25 → $1 | Maintains | Neutral | Get Alert | |
| 03/14/2022 | NKTR | Buy Now | Nektar Therapeutics | $58.80 | -89.8% | $18 → $6 | Downgrade | Neutral → Underperform | Get Alert | |
| 12/03/2021 | STOK | Buy Now | Stoke Therapeutics | $31.81 | 35.18% | → $43 | Initiates | → Buy | Get Alert | |
| 12/03/2021 | AGIO | Buy Now | Agios Pharmaceuticals | $26.85 | 101.12% | → $54 | Initiates | → Buy | Get Alert | |
| 11/19/2021 | ATHX | Buy Now | Athersys | — | — | → $1.25 | Downgrade | Buy → Neutral | Get Alert | |
| 09/10/2021 | NKTR | Buy Now | Nektar Therapeutics | $58.80 | -69.39% | → $18 | Initiates | → Neutral | Get Alert | |
| 09/10/2021 | BEAM | Buy Now | Beam Therapeutics | $26.91 | 457.41% | → $150 | Initiates | → Buy | Get Alert | |
| 06/25/2020 | RCKT | Buy Now | Rocket Pharmaceuticals | $3.42 | 894.15% | → $34 | Reinstates | → Buy | Get Alert | |
| 06/25/2020 | ATHX | Buy Now | Athersys | — | — | → $5 | Initiates | → Buy | Get Alert | |
| 03/16/2020 | NLTX | Buy Now | Neoleukin Therapeutics | — | — | → $18 | Initiates | → Buy | Get Alert | |
| 09/17/2014 | NKTR | Buy Now | Nektar Therapeutics | $58.80 | -81.29% | $10 → $11 | Maintains | Underperform | Get Alert | |
| 11/13/2012 | NKTR | Buy Now | Nektar Therapeutics | $58.80 | -88.1% | $7.5 → $7 | Maintains | Underperform | Get Alert | |
| 01/20/2012 | NKTR | Buy Now | Nektar Therapeutics | $58.80 | -89.8% | → $6 | Downgrade | Neutral → Underperform | Get Alert |
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.